Skip to main content
. 2020 Oct 19;185(2):441–451. doi: 10.1007/s10549-020-05966-y

Table 4.

Crude and adjusted Hazard Ratios (HR) for recurrent disease for mastectomy versus BCS

Crude HR (95%CI)
Mastectomy vs BCS
Adjusteda HR (95%CI)
Mastectomy vs BCS
Recurrent disease 2.127 (1.396–3.241) 1.314 (.812–2.127)

aAdjusted for clinical tumour status (pre-NAC), clinical node status (pre-NAC), subtype, breast pCR, and axillary pCR